{
  "id": "cluster_6_doc2",
  "content": "Patient C702-885J authorization timeline: Initial denial 02/01/2023 citing policy SBT-449Q section 12(b). Appeal submitted 02/15/2023 with additional biomarker evidence. Approval granted 03/15/2023 with 18-month monitoring requirement. Claims department flagged for potential duration exceedances.",
  "metadata": {
    "format": "insurance_memo"
  }
}